The Skin Cancer Foundation Response to the FDA’s Final Order Reclassifying Tanning Beds


New York, NY (May 29, 2014) – The U.S. Food and Drug Administration (FDA) announced a final order today, reclassifying ultraviolet (UV) tanning devices from class I (low to moderate risk) to class II (moderate to high risk) devices. In addition, the FDA will require warning labels on these tanning devices, noting that they should not be used on persons under the age of 18. The Skin Cancer Foundation supports any effort to raise awareness about the hazards of indoor tanning and applauds the FDA for taking this major step in skin cancer prevention.

Today’s announcement follows the order FDA issued in March 2013 initially proposing this reclassification from class I to class II. Class I is the same designation given to elastic bandages and tongue depressors.

Studies offer alarming evidence that indoor tanning bed use increases the risk of melanoma. Just one indoor UV tanning session increases users’ chances of developing melanoma by 20 percent, and each additional session during the same year boosts the risk almost another two percent. Even more alarming, those who begin tanning before age 35 increase their risk by almost 75 percent.

# # #

Contact:

Carla Barry-Austin (212-725-5641; cbarryaustin@skincancer.org)

Emily Prager (212-725-5176; eprager@skincancer.org)
 

About The Skin Cancer Foundation
The Skin Cancer Foundation is the only global organization solely devoted to the prevention, early detection and treatment of skin cancer. The mission of the Foundation is to decrease the incidence of skin cancer through public and professional education and research. Since its inception in 1979, the Foundation has recommended following a complete sun protection regimen that includes seeking shade and covering up with clothing, including a wide-brimmed hat and UV-blocking sunglasses, in addition to daily sunscreen use. For more information, visit SkinCancer.org.